Moorthy, Vasee S.

Rationale for WHO's new position calling for prompt reporting and public disclosure of interventional clinical trial results

Moorthy, V. S., Karam, G., Vannice, K. S., & Kieny, M.-P. (2015) · PLOS Medicine

Pharmaceutical industry and healthcareAcademic Publishing and Open Access

Cited by 155

Design, recruitment, and microbiological considerations in human challenge studies

Darton, T. C., Blohmke, C. J., Moorthy, V. S., Altmann, D. M., Hayden, F. G., Clutterbuck, E. A., Levine, M. M., Hill, A. V. S., & Pollard, A. J. (2015) · The Lancet Infectious Diseases

Ethics in Clinical ResearchBacterial Infections and Vaccines

Cited by 130

WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27–28 April 2016

Kobayashi, M., Schrag, S. J., Alderson, M. R., Madhi, S. A., Baker, C. J., Sobanjo-ter Meulen, A., Kaslow, D. C., Smith, P. G., Moorthy, V. S., & Vekemans, J. (2019) · Vaccine

Neonatal and Maternal InfectionsBacterial Infections and Vaccines

Cited by 105

Reporting summary results in clinical trial registries: updated guidance from WHO

Chan, A.-W., Karam, G., Pymento, J., Askie, L. M., da Silva, L. R., Aymé, S., Taylor, C. M., Hooft, L., Ross, A. L., & Moorthy, V. (2025) · The Lancet Global Health

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 24